
MEI Pharma (MEIP) Earnings Dates & Reports
MEI Pharma (MEIP) Most Recent Earnings
Report DateSep 18, 2024
Period EndingQ4 2024
Est. EPS-$1.43
Actual EPS-$1.12
EarningsBeat
MEI Pharma (MEIP) Earnings
View the latest MEI Pharma (MEIP) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in MEI Pharma (MEIP)
Order type
Buy in
Order amount
Est. shares
0 shares
MEI Pharma (MEIP) Earnings per Share (EPS) History
Signup for full accessBrowse free
MEI Pharma (MEIP) Latest Earnings
The value each MEIP share was expected to gain vs. the value each share gained.
MEI Pharma (MEIP) reported its most recent earnings on Sep 18, 2024 for Q4 2024, posting earnings per share (EPS) of -$1.12. This exceeded analysts' expectations of -$1.43 by 21.68%, marking a Beat.
For comparison, MEI Pharma reported EPS of -$1.51 in the same quarter last year.
The company is expected to announce its next earnings report on 09/18/2025, with analysts projecting an EPS of $0.
MEI Pharma (MEIP) Earnings History
MEI Pharma (MEIP) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the MEI Pharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 13, 2025 | — | — | — |
Feb 12, 2025 | — | — | — |
Nov 12, 2024 | — | — | — |
Sep 19, 2024 | — | — | — |
MEI Pharma (MEIP) Earnings FAQs
MEI Pharma (MEIP) last reported earnings on Sep 18, 2024 for Q4 2024, posting an EPS of -$1.12, which Beat the estimate of -$1.43 by 21.68%.
For Q4 2024, MEI Pharma (MEIP) reported an EPS of -$1.12, exceeding analysts' estimate of -$1.43 by 21.68%.
For Q4 2024, MEI Pharma (MEIP) Beat expectations with an actual EPS of -$1.12 vs. an estimated EPS of -$1.43.
Following the last earnings report on Sep 18, 2024, MEI Pharma (MEIP)'s stock price moved — from — to —.
The next MEI Pharma (MEIP) earnings call is scheduled for Sep. 18, 2025, where executives will discuss financial results and outlook.